Marketed in the U.S. as Chantix and other nations as Champix, another bomb has just fallen on Pfizer's quit smoking pill varenicline. According to a report to be released tomorrow, The Institute for Safe Medication Practices (ISMP), a non-profit medication watchdog, reports that "In the first quarter of 2008, varenicline accounted for more reports of serious injury than the 10 best selling brand name prescription drugs combined."
According to the ISMP report, the U.S. Food and Drug Administration (FDA) received adverse event reports on 773 different drugs during the 1st quarter of 2008. During that time there were 1,001 new reports of serious injuries among varenicline users, including 50 additional deaths. By comparison, during the 4th quarter of 2007 varenicline users accounted for 998 serious injury reports and 78 deaths.
The ISMP report notes that there were only 17 reports of serious injury among all forms of nicotine replacement therapy combined (the nicotine patch, gum, lozenge, spray, and inhaler). This quitting method risk data, when combined with results from the only head-to-head study pitting varenicline against NRT, should allow FDA officials to engaged in more informed risk-benefit analysis.
A February 2008 Pfizer smoking cessation study compared 10 weeks of nicotine patch use to 12 weeks of varenicline use. Even after Pfizer handed varenicline a two-week treatment advantage it failed to prove superior in 7-day point prevelance findings. Participants were asked at both 6 months and 1 year whether or not they had smoked a cigarette in the past 7 days. The reserachers found that there "were no significant differences" between nicotine patch and Chantix smoking abstinence rates at either 6 months or a year.
According to the ISMP report, varenicline again recorded the highest number of suicide/self-harm events of any medication with 226. The combined total for the next two closest drugs reporting suicide attempts was 22% less (oxycodone with 89 reports and acetaminophen with 87).
The ISMP report asserts that broader warnings are needed. It encourages the FDA and Pfizer to add a prominent warning about accident risks to both the patient Medication Guide and prescribing information sheet for doctors, a warning similar to the new warnings about psychiatric side effects.
The ISMP report also flags additional kinds of side effects, including serious accidental injuries. It highlights traffic accidents and concerns that varenicline induced seizures, disturbances in vision, panic attacks or impaired judgment may be playing a role.
It encourages further investigation of possible varenicline links to diabetes, potentially life-threatening interruption of the heart rhythm, heart attacks, strokes, and moderate to severe allergic reactions.
The ISMP's May 2008 report raised concerns about potential alertness and motor control related accidents among transportation industry workers using varenicline. In response, the Federal Aviation Administration banned the use of Chantix by airline pilots, the Department of Transportation limited its use among truck drivers, and the Department of Defense prohibited its use by aircraft and missile crews.
This time the bomb dropped on varenicline may prove fatal. If varenicline is not more effective than NRT, while causing nearly 5,800% greater harm than NRT, then why is it sill on the market? If the FDA has difficulty answering this question, it may well be that our nation's medication system has far greater concerns than just varenicline.XXX
No Copyright - This Article is Public DomainJohn R. Polito is solely responsible for the content of this article.
Any factual error will be immediately corrected upon receipt of credible authority
in support of the writer's contention. E-mail comments to email@example.com
Related Links and Articles
- Despite 98 Suicides and 188 Suicide Attempts Reported Among Chantix Users and No Deaths Reported for E-Cigarettes, FDA Would Rather You Use Chantix - Michael Siegel, MD, 08/31/09
- University of Wisconsin Online Physician Course in Smoking Cessation Therapy Promotes Chantix as First-Line Therapy But Fails to Disclose Drug Risks - Michael Siegel, MD, 03/21/09
- Pfizer's Chantix continues killing smokers - John R. Polito, 10/22/08
- Chantix Lawsuits Piling Up; Dangers from Severe Financial Conflicts of Interests of Tobacco Control Researchers and Institutions Revealed - Michael Siegel, MD, 09/24/08
- Chantix and Champix mental health safety assurances contrary to evidence - John R. Polito, 06/12/08
- Chantix blamed for 3,063 serious injuries and 78 deaths - John R. Polito, 05/21/08
- Strong Safety Signal Seen for New Varenicline Risks - ISMP, 05/21/08
- U.S. quit smoking policy integrity drowns in pharmaceutical influence - John R. Polito, 05/13/08
- Does updated tobacco treatment "Guideline" reflect sham science? - John R. Polito, 05/05/08
- FDA pulls video clip admitting Chantix suicide link - John R. Polito, 04/03/08
- New FDA Chantix suicide risk video clip raises concerns - John R. Polito, 04/02/08
- FDA Chantix Handling Betrayed Public Health - John R. Polito, 02/08
- Windows media clip of WhyQuit's candid views on Chantix & Champix: 18mb video for dial-up users | high res 53mb format | and 7mb audio only format, length 48 minutes, recorded 10/19/07 by Joel Spitzer
- Flawed research equates placebo to cold turkey - John R. Polito, 03/07
- Nicotine Fix - Behind Antismoking Policy, Influence of Drug Industry - Kevin Helliker, 02/07
- Evidence of Collusion: Pharma-Govt Smoking Guidelines - AHRP, 02/07
- WSJ Highlights Financial Conflicts of Chair of Federal Guidelines Panel - Michael Siegel, MD 02/07
- Nixing the Patch: Smokers quit cold turkey - Ken Millstone, 02/07
- The secret to quitting smoking - John R. Polito, 01/07
- Financial Ties Between Guideline Panels and Big Pharma Run Deep - Michael Siegel, MD, 01/07
- Chantix - an 8 in 10 failure rate or worse? - John R. Polito, 12/06
- Do physician's have a legal duty to ignore Guideline Recommendation 7? - John R. Polito, 12/06
- Chantix likely as ineffective as NRT - John R. Polito, 11/06
- Is the U.S. government's quitting policy killing smokers? - John R. Polito, 10/06
- Will Chantix really help me quit smoking? - John R. Polito, 08/06
- It's unlikely this NRT study was blind - John R. Polito, 08/06
- Conference Sponsorship by Pharma Precludes Objective Symposium - Michael Siegel, MD 07/06
- 13th World Conference on Tobacco or Health Drenched in Nicotine - John R. Polito, 07/06
- Cold Turkey Twice as Effective as NRT or Zyban - John R. Polito, 05/06
- June 2000 Guideline Chairman Michael Fiore's Testimony - see PDF pages 14 & 15, 05/05
- The Nicotine Patch, Gum and Lozenge - Mounting Evidence of a Sham - John R. Polito, 04/05
- 40 Years of Progress? - Joel Spitzer, 10/04
- Widespread Blinding Failures Put NRT Studies in Serious Question - John R. Polito, 06/04
- A Quitter's Dilemma: Hooked on the Cure - New York Times, 05/04
WhyQuit's basic "how to quit smoking" video